Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KRYS | HALO | CDTX | ||
| Company | Krystal Biotech Inc | Halozyme Therapeutic | Cidara Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 244.34 | 62.14 | 220.45 | ||
| High | 247.40 | 63.52 | 220.45 | ||
| Low | 240.49 | 61.69 | 219.79 | ||
| Latest | 242.98 | 63.45 | 220.10 | ||
| Change | -1.67 | +1.24 | -0.55 | ||
| % Change | -0.68% | +1.99% | -0.25% | ||
| Volume | 243,600 | 2,102,700 | 1,320,900 | ||
| 20-Day Average Volume | 292,650 | 2,515,545 | 1,510,205 | ||
| Previous Close | 244.65 | 62.21 | 220.65 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 222.42 | 67.08 | 219.81 | ||
| 20-Day Raw Stochastic | 87.69% | 17.08% | 70.98% | ||
| 20-Day Relative Strength | 76.05 | 41.03 | 83.32 | ||
| Weighted Alpha | +68.53 | +26.12 | +182.10 | ||
| Today's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 24% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.82% since 12/08/25 | +0.91% since 12/08/25 | +0.01% since 12/08/25 | ||
| Low | 231.51 on 12/09/25 | 61.22 on 12/11/25 | 219.60 on 12/10/25 | ||
| High | 248.60 on 12/12/25 | 63.52 on 12/15/25 | 220.78 on 12/12/25 | ||
| 1-Month | |||||
| %Chg | +17.86% since 11/14/25 | -9.40% since 11/14/25 | +1.10% since 11/14/25 | ||
| Low | 202.99 on 11/18/25 | 61.22 on 12/11/25 | 217.41 on 11/17/25 | ||
| High | 248.60 on 12/12/25 | 74.25 on 11/26/25 | 221.20 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | +56.05% since 09/15/25 | -16.87% since 09/15/25 | +228.95% since 09/15/25 | ||
| Low | 151.88 on 09/16/25 | 61.22 on 12/11/25 | 64.01 on 09/17/25 | ||
| High | 248.60 on 12/12/25 | 79.50 on 09/23/25 | 221.20 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +77.27% since 06/13/25 | +17.54% since 06/13/25 | +863.66% since 06/13/25 | ||
| Low | 127.99 on 06/18/25 | 51.06 on 06/30/25 | 20.16 on 06/20/25 | ||
| High | 248.60 on 12/12/25 | 79.50 on 09/23/25 | 221.20 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,094,358 | 7,315,710 | 6,937,013 | ||
| Shares Outstanding, K | 28,998 | 117,597 | 31,439 | ||
| Annual Sales | 290,520,000 | 1,015,320,000 | 1,280,000 | ||
| Annual Net Income | 89,160,000 | 444,090,000 | -169,830,000 | ||
| Last Quarter Sales | 97,800,000 | 354,260,000 | 0 | ||
| Last Quarter Net Income | 79,370,000 | 175,230,000 | -83,230,000 | ||
| 60-Month Beta | 0.48 | 0.95 | 1.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.66 on 11/03/25 | 1.72 on 11/03/25 | -1.43 on 11/06/25 | ||
| Latest Earnings Date | 02/18/26 | 02/17/26 | 03/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 37.00 | 11.64 | 0.00 | ||